An objective validation of polyp and instrument segmentation methods in colonoscopy through Medico 2020 polyp segmentation and MedAI 2021 transparency challenges

Automatic analysis of colonoscopy images has been an active field of research motivated by the importance of early detection of precancerous polyps. However, detecting polyps during the live examination can be challenging due to various factors such as variation of skills and experience among the endoscopists, lack of attentiveness, and fatigue leading to a high polyp miss-rate. Deep learning has emerged as a promising solution to this challenge as it can assist endoscopists in detecting and classifying overlooked polyps and abnormalities in real time. In addition to the algorithm's accuracy, transparency and interpretability are crucial to explaining the whys and hows of the algorithm's prediction. Further, most algorithms are developed in private data, closed source, or proprietary software, and methods lack reproducibility. Therefore, to promote the development of efficient and transparent methods, we have organized the "Medico automatic polyp segmentation (Medico 2020)" and "MedAI: Transparency in Medical Image Segmentation (MedAI 2021)" competitions. We present a comprehensive summary and analyze each contribution, highlight the strength of the best-performing methods, and discuss the possibility of clinical translations of such methods into the clinic. For the transparency task, a multi-disciplinary team, including expert gastroenterologists, accessed each submission and evaluated the team based on open-source practices, failure case analysis, ablation studies, usability and understandability of evaluations to gain a deeper understanding of the models' credibility for clinical deployment. Through the comprehensive analysis of the challenge, we not only highlight the advancements in polyp and surgical instrument segmentation but also encourage qualitative evaluation for building more transparent and understandable AI-based colonoscopy systems.

GastroVision: A Multi-class Endoscopy Image Dataset for Computer Aided Gastrointestinal Disease Detection

Integrating real-time artificial intelligence (AI) systems in clinical practices faces challenges such as scalability and acceptance. These challenges include data availability, biased outcomes, data quality, lack of transparency, and underperformance on unseen datasets from different distributions. The scarcity of large-scale, precisely labeled, and diverse datasets are the major challenge for clinical integration. This scarcity is also due to the legal restrictions and extensive manual efforts required for accurate annotations from clinicians. To address these challenges, we present GastroVision, a multi-center open-access gastrointestinal (GI) endoscopy dataset that includes different anatomical landmarks, pathological abnormalities, polyp removal cases and normal findings (a total of 24 classes) from the GI tract. The dataset comprises 8,000 images acquired from B{\ae}rum Hospital in Norway and Karolinska University in Sweden and was annotated and verified by experienced GI endoscopists. Furthermore, we validate the significance of our dataset with extensive benchmarking based on the popular deep learning based baseline models. We believe our dataset can facilitate the development of AI-based algorithms for GI disease detection and classification. Our dataset is available at https://osf.io/84e7f/.

TransRUPNet for Improved Out-of-Distribution Generalization in Polyp Segmentation

Out-of-distribution (OOD) generalization is a critical challenge in deep learning. It is specifically important when the test samples are drawn from a different distribution than the training data. We develop a novel real-time deep learning based architecture, TransRUPNet that is based on a Transformer and residual upsampling network for colorectal polyp segmentation to improve OOD generalization. The proposed architecture, TransRUPNet, is an encoder-decoder network that consists of three encoder blocks, three decoder blocks, and some additional upsampling blocks at the end of the network. With the image size of $256\times256$, the proposed method achieves an excellent real-time operation speed of \textbf{47.07} frames per second with an average mean dice coefficient score of 0.7786 and mean Intersection over Union of 0.7210 on the out-of-distribution polyp datasets. The results on the publicly available PolypGen dataset (OOD dataset in our case) suggest that TransRUPNet can give real-time feedback while retaining high accuracy for in-distribution dataset. Furthermore, we demonstrate the generalizability of the proposed method by showing that it significantly improves performance on OOD datasets compared to the existing methods.

Self-Supervised Learning for Organs At Risk and Tumor Segmentation with Uncertainty Quantification

In this study, our goal is to show the impact of self-supervised pre-training of transformers for organ at risk (OAR) and tumor segmentation as compared to costly fully-supervised learning. The proposed algorithm is called Monte Carlo Transformer based U-Net (MC-Swin-U). Unlike many other available models, our approach presents uncertainty quantification with Monte Carlo dropout strategy while generating its voxel-wise prediction. We test and validate the proposed model on both public and one private datasets and evaluate the gross tumor volume (GTV) as well as nearby risky organs' boundaries. We show that self-supervised pre-training approach improves the segmentation scores significantly while providing additional benefits for avoiding large-scale annotation costs.

Ensuring Trustworthy Medical Artificial Intelligence through Ethical and Philosophical Principles

Artificial intelligence (AI) methods have great potential to revolutionize numerous medical care by enhancing the experience of medical experts and patients. AI based computer-assisted diagnosis tools can have a tremendous benefit if they can outperform or perform similarly to the level of a clinical expert. As a result, advanced healthcare services can be affordable in developing nations, and the problem of a lack of expert medical practitioners can be addressed. AI based tools can save time, resources, and overall cost for patient treatment. Furthermore, in contrast to humans, AI can uncover complex relations in the data from a large set of inputs and even lead to new evidence-based knowledge in medicine. However, integrating AI in healthcare raises several ethical and philosophical concerns, such as bias, transparency, autonomy, responsibility and accountability, which must be addressed before integrating such tools into clinical settings. In this article, we emphasize recent advances in AI-assisted medical image analysis, existing standards, and the significance of comprehending ethical issues and best practices for the applications of AI in clinical settings. We cover the technical and ethical challenges of AI and the implications of deploying AI in hospitals and public organizations. We also discuss promising key measures and techniques to address the ethical challenges, data scarcity, racial bias, lack of transparency, and algorithmic bias. Finally, we provide our recommendation and future directions for addressing the ethical challenges associated with AI in healthcare applications, with the goal of deploying AI into the clinical settings to make the workflow more efficient, accurate, accessible, transparent, and reliable for the patient worldwide.

Ensuring Trustworthy Medical Artificial Intelligencethrough Ethical and Philosophical Principles

Artificial intelligence (AI) methods have great potential to revolutionize numerous medical care by enhancing the experience of medical experts and patients. AI based computer-assisted diagnosis tools can have a tremendous benefit if they can outperform or perform similarly to the level of a clinical expert. As a result, advanced healthcare services can be affordable in developing nations, and the problem of a lack of expert medical practitioners can be addressed. AI based tools can save time, resources, and overall cost for patient treatment. Furthermore, in contrast to humans, AI can uncover complex relations in the data from a large set of inputs and even lead to new evidence-based knowledge in medicine. However, integrating AI in healthcare raises several ethical and philosophical concerns, such as bias, transparency, autonomy, responsibility and accountability, which must be addressed before integrating such tools into clinical settings. In this article, we emphasize recent advances in AI-assisted medical image analysis, existing standards, and the significance of comprehending ethical issues and best practices for the applications of AI in clinical settings. We cover the technical and ethical challenges of AI and the implications of deploying AI in hospitals and public organizations. We also discuss promising key measures and techniques to address the ethical challenges, data scarcity, racial bias, lack of transparency, and algorithmic bias. Finally, we provide our recommendation and future directions for addressing the ethical challenges associated with AI in healthcare applications, with the goal of deploying AI into the clinical settings to make the workflow more efficient, accurate, accessible, transparent, and reliable for the patient worldwide.

Vision Transformer for Efficient Chest X-ray and Gastrointestinal Image Classification

Medical image analysis is a hot research topic because of its usefulness in different clinical applications, such as early disease diagnosis and treatment. Convolutional neural networks (CNNs) have become the de-facto standard in medical image analysis tasks because of their ability to learn complex features from the available datasets, which makes them surpass humans in many image-understanding tasks. In addition to CNNs, transformer architectures also have gained popularity for medical image analysis tasks. However, despite progress in the field, there are still potential areas for improvement. This study uses different CNNs and transformer-based methods with a wide range of data augmentation techniques. We evaluated their performance on three medical image datasets from different modalities. We evaluated and compared the performance of the vision transformer model with other state-of-the-art (SOTA) pre-trained CNN networks. For Chest X-ray, our vision transformer model achieved the highest F1 score of 0.9532, recall of 0.9533, Matthews correlation coefficient (MCC) of 0.9259, and ROC-AUC score of 0.97. Similarly, for the Kvasir dataset, we achieved an F1 score of 0.9436, recall of 0.9437, MCC of 0.9360, and ROC-AUC score of 0.97. For the Kvasir-Capsule (a large-scale VCE dataset), our ViT model achieved a weighted F1-score of 0.7156, recall of 0.7182, MCC of 0.3705, and ROC-AUC score of 0.57. We found that our transformer-based models were better or more effective than various CNN models for classifying different anatomical structures, findings, and abnormalities. Our model showed improvement over the CNN-based approaches and suggests that it could be used as a new benchmarking algorithm for algorithm development.

Domain Generalization with Adversarial Intensity Attack for Medical Image Segmentation

Most statistical learning algorithms rely on an over-simplified assumption, that is, the train and test data are independent and identically distributed. In real-world scenarios, however, it is common for models to encounter data from new and different domains to which they were not exposed to during training. This is often the case in medical imaging applications due to differences in acquisition devices, imaging protocols, and patient characteristics. To address this problem, domain generalization (DG) is a promising direction as it enables models to handle data from previously unseen domains by learning domain-invariant features robust to variations across different domains. To this end, we introduce a novel DG method called Adversarial Intensity Attack (AdverIN), which leverages adversarial training to generate training data with an infinite number of styles and increase data diversity while preserving essential content information. We conduct extensive evaluation experiments on various multi-domain segmentation datasets, including 2D retinal fundus optic disc/cup and 3D prostate MRI. Our results demonstrate that AdverIN significantly improves the generalization ability of the segmentation models, achieving significant improvement on these challenging datasets. Code is available upon publication.

TransNetR: Transformer-based Residual Network for Polyp Segmentation with Multi-Center Out-of-Distribution Testing

Colonoscopy is considered the most effective screening test to detect colorectal cancer (CRC) and its precursor lesions, i.e., polyps. However, the procedure experiences high miss rates due to polyp heterogeneity and inter-observer dependency. Hence, several deep learning powered systems have been proposed considering the criticality of polyp detection and segmentation in clinical practices. Despite achieving improved outcomes, the existing automated approaches are inefficient in attaining real-time processing speed. Moreover, they suffer from a significant performance drop when evaluated on inter-patient data, especially those collected from different centers. Therefore, we intend to develop a novel real-time deep learning based architecture, Transformer based Residual network (TransNetR), for colon polyp segmentation and evaluate its diagnostic performance. The proposed architecture, TransNetR, is an encoder-decoder network that consists of a pre-trained ResNet50 as the encoder, three decoder blocks, and an upsampling layer at the end of the network. TransNetR obtains a high dice coefficient of 0.8706 and a mean Intersection over union of 0.8016 and retains a real-time processing speed of 54.60 on the Kvasir-SEG dataset. Apart from this, the major contribution of the work lies in exploring the generalizability of the TransNetR by testing the proposed algorithm on the out-of-distribution (test distribution is unknown and different from training distribution) dataset. As a use case, we tested our proposed algorithm on the PolypGen (6 unique centers) dataset and two other popular polyp segmentation benchmarking datasets. We obtained state-of-the-art performance on all three datasets during out-of-distribution testing. The source code of TransNetR will be made publicly available at https://github.com/DebeshJha.